Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;465(5):547-58.
doi: 10.1007/s00428-014-1634-2. Epub 2014 Aug 3.

FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer

An Na Seo  1 , Yan Jin, Hee Jin Lee, Ping-Li Sun, Hyojin Kim, Sanghoon Jheon, Kwhanmien Kim, Choon-Taek Lee, Jin-Haeng Chung
Affiliations

FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer

An Na Seo et al. Virchows Arch. 2014 Nov.

Abstract

FGFR1 amplification has been identified recently as an important therapeutic target in non-small-cell lung cancer (NSCLC), particularly squamous cell carcinoma (SqCC). However, data from previous studies on the clinical implications of FGFR amplification in NSCLC are inconsistent. We evaluated FGFR1 gene copy number (GCN) in 369 cases of surgically resected NSCLC using five previously reported criteria and investigated associations between clinicopathologic parameters and FGFR1 amplification. FGFR1 amplification was found in 32/369 (8.7 %) of NSCLC and was more frequent in SqCC (18.0 % in SqCC, 3.0 % in adenocarcinoma; p < 0.001) and in smokers (p < 0.001). On univariate analysis, FGFR1 amplification was significantly associated with shorter overall survival (OS, 58.6 vs 80.0 months; p = 0.033) and shorter disease-free survival (DFS, 58.5 vs 80.0 months; p = 0.042) in patients with SqCC, but this was not statistically significant on multivariate analysis (OS: hazard ratio [HR] = 1.79, 95 % confidence interval [CI] = 0.83-3.87, p = 0.139; DFS: HR = 1.73, 95 % CI = 0.93-3.21, p = 0.081). The correlation between FGFR1 amplification and protein expression was poor (rho = 0.08; p = 0.123). These results suggest that FGFR1 amplification is associated with smoking history and squamous cell carcinoma histology and might indicate poor prognosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lung Cancer. 2013 Sep;81(3):462-467 - PubMed
    1. Virchows Arch. 2012 Jul;461(1):49-57 - PubMed
    1. J Thorac Oncol. 2010 Jul;5(7):964-9 - PubMed
    1. Curr Cancer Drug Targets. 2012 Feb;12(2):107-23 - PubMed
    1. J Exp Clin Cancer Res. 2012 Dec 27;31:103 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources